Recent Accretive Acquisition, Up-listing to NASDAQ and an FDA Approved Product, Feature Report

New York, NY -- September 14, 2020 -- InvestorsHub NewsWire -- via Traders News Source, a leading independent equity research and corporate access firm focused on small cap growth companies issues a new research report.

Revive Therapeutics Ltd. (OTCPINK: RVVTF) is a specialty life sciences company. Following the U.S. Food & Drug Administration approval to proceed with the Company’s Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19, the Company has submitted its clinical trial protocol for independent Institutional Review Board ("IRB") approval. Also, the company is exploring the FDA Expanded Access Program, that can provide access to, Bucillamine, for people who meet the protocol criteria of the COVID-19 study.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), is a leading developer of spider silk-based fibers. Viral diseases can result in total annual silk production losses of as much as 32%. Kraig Labs has developed its first immune-enhancing genetic insert, designed to create disease-resistant silkworms. Global silk production is expected to reach USD 17 billion in 2021; the economic impact of eliminating the loss from disease is a multi-billion-dollar opportunity. The Company anticipates that its development of a disease resistant silkworm could be licensed across the entire global silk industry.

What’s hot right now? follow the link to see our full feature report READ MORE
Copy and paste to browser may be required: https://tradersnewssource.com/potential-home-run-stock/

DSG Global Inc. (OTCQB: DSGT), is a technology development company engaged in the design, manufacture, sales, and leasing of GPS tracking devices. The company's subsidiary, Imperium Motor Co., a new EV brand and EVRUS, LLC, a privately-held company engaging in the design, manufacture and market electric vehicle fast charging stations, announced that they have executed a Letter of Intent relating to a proposed joint venture of Imperium and EV Express®.

iGen Networks Corp. (OTCQB: IGEN) is a leading innovator of cloud-based and Internet of Things (IoT) automotive solutions. The company recently announced the launch of its Next-Generation Platform built on the Amazon's Web Service (AWS) infrastructure and based on state-of-the-art coding methodology that leverages Facebook and Google design techniques to present a seamless user interface regardless of access methods including smartphones, tablets, desktops, and third party application environments.

Our full featured stock report is available with no obligation READ MORE
Copy and paste to browser may be required: https://tradersnewssource.com/potential-home-run-stock/

Disclosure

Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ, and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps.

TNS LLC has listed if any, all compensation in the linked full report

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the "Author"). Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS.

NO WARRANTY

TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer be featured on our coverage list, contact us via email at: editor@tradersnewssource.com

CONTACT: editor@tradersnewssource.com
SOURCE: Traders News Source